Europe Non-Alcoholic Steatopatitis Market Estimated To Account For A Higher Value By 2028; With a Whooping CAGR

According to a new market research study on the Europe Non-Alcoholic Steatopatitis Market Forecast to 2028 –– by product, application, sales channel and countries is expected to reach US$ 12,963.42 million by 2028 from US$ 838.07 million in 2021. The market is estimated to grow at a CAGR of 47.9% from 2021 to 2028. The report provides trends prevailing in the Europe Non-Alcoholic Steatohepatitis market along with the drivers and restraints pertaining to the market growth. Rising prevalence of NASH is the major factor driving the growth of the Europe Non-Alcoholic Steatohepatitis market. However, issues associated with stringent regulations related to Non-Alcoholic Steatohepatitis the growth of Europe Non-Alcoholic Steatohepatitis market.

Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00025404

The List of Companies 

  1. Cadila Pharmaceutical.
  2. Intercept Pharmaceutical.
  3. Novartis AG.
  4. Galmed Pharmaceutical.
  5. GENFIT.
  6. ONE WAY LIVER SI.
  7. BioPredictive S.A.S.
  8. Siemens Healthineers AG.
  9. Laboratory Corporation of America Holdings.

Non-Alcoholic Steatohepatitis (NASH) is an under-recognized condition, making it crucial to increase awareness among both the general public and primary care physicians (PCPs). Enhancing awareness can facilitate early detection and establish a structured referral pathway, ensuring that more individuals receive timely specialist evaluation. By implementing clear patient referral processes and public education campaigns, the number of diagnosed cases can increase, ultimately expanding the patient pool.

To address this need, the NASH Education Program launched a public education campaign on June 12, 2018, marking "International NASH Day" to raise awareness about non-alcoholic fatty liver disease (NAFLD) and its advanced form, NASH, which affects over 115 million people worldwide. Following this initiative, NASH 24X7, a digital platform dedicated to increasing awareness about the growing NASH epidemic, took significant steps on International NASH Day, June 12, 2019. These efforts included healthcare provider (HCP) support, patient education, and press and television outreach programs.

In terms of patient education, NASH Crusaders, a branch of NASH 24X7, collaborated with HCPs across India to conduct numerous small and large-scale workshops focused on liver health and the importance of a healthy lifestyle in preventing NAFLD/NASH. Additionally, various awareness initiatives were carried out on International NASH Day, including press releases, television programs, and engagement through digital and print media to reach a broader audience.

With growing awareness and increased diagnosis, the European NASH market is expected to expand at a strong CAGR during the forecast period.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Popular posts from this blog

Graphite Market Opportunities, Challenges, Strategies and Forecasts by 2031

Permanent Magnet Market Size, Share, Segmentation, Analysis by Recent Trends, Development and Growth by 2031

Europe Hair Color Market Analysis, Trends, Share, Development Policies, and Future Growth 2031